Latest Insider Transactions at Aura Biosciences, Inc. (AURA)
This section provides a real-time view of insider transactions for Aura Biosciences, Inc. (AURA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aura Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aura Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 29
2024
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct |
9,200
-2.79%
|
$92,000
$10.74 P/Share
|
|
Oct 29
2024
|
Amy Elazzouzi Vice President, Finance |
SELL
Open market or private sale
|
Direct |
553
-1.38%
|
$5,530
$10.74 P/Share
|
|
Oct 18
2024
|
Julie B Feder Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,131
-15.77%
|
$301,572
$12.03 P/Share
|
|
Oct 18
2024
|
Julie B Feder Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,131
+5.02%
|
$100,524
$4.16 P/Share
|
|
Oct 18
2024
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct |
24,992
-7.04%
|
$299,904
$12.04 P/Share
|
|
Oct 18
2024
|
Pinos Elisabet De Los |
BUY
Exercise of conversion of derivative security
|
Direct |
24,992
+6.58%
|
$49,984
$2.74 P/Share
|
|
Oct 16
2024
|
Mark Plavsic Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
7,383
-5.74%
|
$66,447
$9.85 P/Share
|
|
Sep 27
2024
|
Pinos Elisabet De Los |
BUY
Exercise of conversion of derivative security
|
Direct |
5,474
+1.63%
|
$27,370
$5.76 P/Share
|
|
Jun 20
2024
|
David Michael Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+6.7%
|
-
|
|
Jun 20
2024
|
Sapna Srivastava |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
|
Jun 20
2024
|
Antony C. Mattessich |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
|
Apr 02
2024
|
Conor Kilroy General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
96,000
+50.0%
|
-
|
|
Feb 01
2024
|
Pinos Elisabet De Los |
BUY
Grant, award, or other acquisition
|
Direct |
162,935
+33.44%
|
-
|
|
Feb 01
2024
|
Julie B Feder Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
71,285
+34.68%
|
-
|
|
Feb 01
2024
|
Janet Jill Hopkins Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,515
+14.85%
|
-
|
|
Jan 23
2024
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct |
15,853
-8.94%
|
$110,971
$7.64 P/Share
|
|
Jan 23
2024
|
Julie B Feder Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,609
-9.5%
|
$46,263
$7.64 P/Share
|
|
Nov 09
2023
|
Matrix Capital Management Company, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,560,000
+18.39%
|
$14,040,000
$9.0 P/Share
|
|
Nov 08
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Indirect |
20,000
+11.76%
|
$140,000
$7.3 P/Share
|
|
Nov 08
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Direct |
9,601
+6.61%
|
$67,207
$7.3 P/Share
|
|
Nov 07
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Indirect |
94,000
+41.96%
|
$658,000
$7.17 P/Share
|
|
Nov 07
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Direct |
76,000
+37.61%
|
$532,000
$7.17 P/Share
|
|
Nov 06
2023
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct |
7,449
-4.03%
|
$89,388
$12.03 P/Share
|
|
Nov 06
2023
|
Pinos Elisabet De Los |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+2.02%
|
$7,600
$2.74 P/Share
|
|
Nov 06
2023
|
Julie B Feder Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,900
-5.31%
|
$46,800
$12.07 P/Share
|
|
Nov 06
2023
|
Julie B Feder Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+5.04%
|
$7,800
$2.74 P/Share
|
|
Nov 01
2023
|
Janet Jill Hopkins Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
135,000
+50.0%
|
-
|
|
Oct 30
2023
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct |
9,586
-5.03%
|
$57,516
$6.83 P/Share
|
|
Oct 30
2023
|
Julie B Feder Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,385
-4.64%
|
$20,310
$6.82 P/Share
|
|
Oct 04
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Direct |
6,566
+11.59%
|
$52,528
$8.61 P/Share
|
|
Oct 03
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Direct |
13,500
+23.68%
|
$108,000
$8.27 P/Share
|
|
Jan 19
2023
|
Cadmus Rich Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,125
+36.76%
|
-
|
|
Jan 19
2023
|
Pinos Elisabet De Los |
BUY
Grant, award, or other acquisition
|
Direct |
121,875
+39.01%
|
-
|
|
Jan 19
2023
|
Mark De Rosch Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,250
+41.88%
|
-
|
|
Jan 19
2023
|
Julie B Feder Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,750
+40.05%
|
-
|
|
Jan 06
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Indirect |
1,604
+4.26%
|
$16,040
$10.51 P/Share
|
|
Jan 05
2023
|
David Michael Johnson |
BUY
Open market or private purchase
|
Indirect |
396
+1.13%
|
$3,960
$10.0 P/Share
|
|
Dec 28
2022
|
David Michael Johnson |
BUY
Open market or private purchase
|
Indirect |
4,000
+10.53%
|
$36,000
$9.75 P/Share
|
|
Dec 05
2022
|
Matrix Capital Management Company, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,250,000
+18.9%
|
$15,000,000
$12.0 P/Share
|
|
Dec 01
2022
|
David Michael Johnson |
BUY
Open market or private purchase
|
Indirect |
10,000
+25.0%
|
$120,000
$12.37 P/Share
|
|
Oct 31
2022
|
Mark De Rosch Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,115
-6.37%
|
$13,380
$12.46 P/Share
|
|
Oct 31
2022
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct |
5,706
-7.67%
|
$68,472
$12.46 P/Share
|
|
Oct 31
2022
|
Cadmus Rich Officer |
SELL
Open market or private sale
|
Direct |
1,672
-6.37%
|
$20,064
$12.45 P/Share
|
|
Oct 31
2022
|
Julie B Feder Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,015
-7.68%
|
$24,180
$12.45 P/Share
|
|
Jun 13
2022
|
David Michael Johnson |
BUY
Open market or private purchase
|
Direct |
20,000
+40.0%
|
$260,000
$13.99 P/Share
|
|
Jun 13
2022
|
David Michael Johnson |
BUY
Open market or private purchase
|
Indirect |
14,000
+41.18%
|
$182,000
$13.99 P/Share
|
|
Jun 10
2022
|
David Michael Johnson |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$150,000
$15.04 P/Share
|
|
Jun 10
2022
|
David Michael Johnson |
BUY
Open market or private purchase
|
Indirect |
6,000
+50.0%
|
$90,000
$15.04 P/Share
|
|
Nov 02
2021
|
Matrix Capital Management Company, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,785,000
+30.27%
|
$24,990,000
$14.0 P/Share
|
|
Nov 02
2021
|
Matrix Capital Management Company, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,327,870
+50.0%
|
-
|